Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of and interventions with, people who have diabetes or are at increased risk of developing diabetes. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands and Director of The Real World Evidence Unit. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He has published over 500 articles.
Professor Khunti is a Fellow of the Academy of Medical Sciences and is currently an advisor to the Department of Health, a Clinical Advisor for the National Institute for Health and Care Excellence (NICE) and Secretary of the Primary Care Study Group of the European Association for the Study of Diabetes. He is Past Chair of the Department of Health– Royal College of General Practitioners (RCGP) Committee on Classification of Diabetes and is Past Chair of the NICE Guidelines on Prevention of Diabetes. In addition, he is Co-Director of the Diabetes MSc at Leicester University. He has won numerous awards nationally and internationally.
Grants/research supports: Lilly, Sanofi- Aventis, Boehringer Ingelheim, MSD, Novo Nordisk
Receipt of honoraria or consultation fees: Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Servier, MSD, Astrazeneca, Roche, NAPP, Amgen, Bayer, Berlin-Chemie AG / Menarini Grou